Fangming Lin

Fangming Lin is a seasoned professional in the pharmaceutical industry with extensive experience in quality and compliance. Currently serving as Director of Quality and Compliance at Alexion Pharmaceuticals, Inc. since January 2021, Fangming Lin previously held the role of Director, Quality Assurance GMP/CMC at Centrexion Therapeutics Corp. from January 2020 to January 2021. Prior to that, a strong background in quality assurance was established at GSK as a Quality Assurance Compliance Manager from January 2015 to January 2020. Fangming Lin also contributed to Novartis Pharmaceuticals Corp. and Novartis Consumer Health in various capacities, including Manager of Quality Systems and Standards and Senior Scientist, from January 2004 to January 2015. Fangming Lin began a career in pharmaceuticals as a Chemist at Pfizer from January 2003 to January 2004. Educationally, Fangming Lin holds a Master of Business Administration (MBA) from Fairleigh Dickinson University.